MAPT and Alzheimer disease: There was a non-statistically significant trend towards decreased Aβ1-42 CSF levels between groups (n=19 negligible-low AD-tau, n=10 medium-high AD-tau; p=0.155 Mann-Whitney Rank Sum test).